The provided sources focus on:
None of these materials mention "RANK Human" or any compound explicitly matching this name.
The term "RANK" could refer to:
Receptor Activator of Nuclear Factor Kappa-B (RANK), a protein involved in osteoclast differentiation and immune regulation. This protein is well-documented in bone biology but is unrelated to the chemical or toxicological contexts in the provided sources.
Ranking systems for chemicals or researchers, as seen in sources , but these are unrelated to a compound named "RANK Human."
To resolve ambiguity or validate the compound’s existence:
Cross-check chemical registries (e.g., PubChem, ChEMBL) for standardized nomenclature.
Verify peer-reviewed literature via platforms like PubMed or Web of Science.
Consult domain-specific databases such as Tox21 ( ) or the Human Pangenome Reference ( ) for genomic associations.
The absence of "RANK Human" in the reviewed sources suggests:
TNFRSF11A, ODFR, RANK, Tumor Necrosis Factor Receptor Superfamily, Member 11a, Activator Of NFKB, Receptor Activator Of Nuclear Factor-Kappa B, CD265 Antigen, LOH18CR1, TRANCER, CD265
The RANK/RANKL (Receptor Activator of Nuclear Factor-kappa B Ligand) pathway plays a fundamental role in regulating bone remodeling through osteoclast differentiation and survival. While expressed in various tissues including kidney, liver, thymus, and lung, RANK and RANKL are most strongly expressed in bone tissue, consistent with their primary regulatory role in bone metabolism. Additionally, RANKL signaling contributes significantly to immune system function through the activation and survival of T cells, positioning this pathway at the critical intersection of bone metabolism and immunity . Research methodologically approaches RANK/RANKL studies by examining expression patterns across different tissue types and analyzing how perturbations affect both bone structure and immune response.
RANK/RANKL signaling has been implicated in multiple stages of tumorigenesis, from initial cell proliferation and carcinogenesis to epithelial-mesenchymal transition, neoangiogenesis, intravasation, metastasis, bone resorption, and tumor growth in bone. In multiple myeloma specifically, patients demonstrate increased serum levels of soluble RANKL and an imbalance between RANKL and osteoprotegerin . Methodologically, researchers investigate this pathway through measurement of serum RANKL levels, analysis of RANKL/osteoprotegerin ratios, and examination of RANKL expression in both tumor cells and osteoprogenitor cells. When designing studies on RANK/RANKL in cancer, researchers must incorporate multiple assessment points to capture the pathway's influence across different stages of cancer progression.
For a project to qualify as Human Subjects Research (HSR) requiring Institutional Review Board (IRB) approval, it must meet two essential criteria. First, it must constitute research through systematic investigation designed to develop or contribute to generalizable knowledge. Second, it must involve human subjects, defined as living individuals about whom researchers either: a) obtain information or biospecimens through intervention or interaction, or b) acquire, use, study, analyze, or generate identifiable private information or biospecimens . Methodologically, researchers should note that "interactions" extend beyond in-person contact to include emails, online surveys, and interviews via telephone or videoconferencing. Projects meeting both criteria cannot begin until reviewed and approved by the IRB, establishing a procedural framework that ensures ethical research practices.
Predicting human responses to compounds affecting RANK/RANKL pathways requires integrating multiple data types. The DREAM challenge methodology demonstrated that algorithms can predict toxicities of environmental compounds with potential adverse health effects for human populations by combining cytotoxicity data from lymphoblastoid cell lines with genotype and transcriptional information . While individual cytotoxicity predictions showed modest correlations (Pearson's r < 0.28), population-level response predictions achieved higher accuracy (r < 0.66) . Methodologically, researchers should implement computational models that account for both genomic profiles and structural attributes of compounds, acknowledging that prediction accuracy for individual responses remains suboptimal due to the complexity of genetic variations influencing toxic responses.
When designing studies to evaluate individual variability in RANK/RANKL expression, researchers should employ strategies that account for genetic diversity and population-level differences. Methodologically, a community-based approach like that used in the DREAM challenge provides a framework for incorporating genotype and transcriptional data . To effectively analyze interindividual variability, researchers should:
Collect genomic profiles alongside RANK/RANKL expression data
Implement statistical methods that account for complex trait genomic prediction
Design experiments with sufficient statistical power to detect subtle individual differences
Consider environmental factors that may influence expression patterns
Validate findings across diverse population samples
This approach recognizes that while individual-level predictions remain challenging, population-level analyses may yield more robust insights into RANK/RANKL variability.
Advanced computational methods for analyzing RANK/RANKL pathway interactions require integration of structural, genetic, and population-level data. Based on approaches from the DREAM challenge and similar computational toxicology studies, effective methodologies include:
Computational Method | Application to RANK/RANKL Research | Relative Accuracy |
---|---|---|
Machine Learning Algorithms | Predicting compound effects on RANK/RANKL pathways | Moderate (r < 0.28 for individual predictions) |
Population-based Modeling | Assessing group-level responses to RANK/RANKL modulation | High (r < 0.66) |
Genomic Profile Integration | Correlating genetic variants with RANK/RANKL expression | Moderate |
Structural Attribute Analysis | Predicting how compounds interact with RANK/RANKL | Moderate to High |
Researchers should recognize that while computational methods provide valuable insights, they remain "suboptimal" for precise individual-level predictions, necessitating experimental validation of computational findings.
Studying the relationship between RANK/RANKL and immune system function requires methodological approaches that bridge bone metabolism and immunology. RANKL is considered "one of the key factors at the crossroads of bone metabolism and immunity" , necessitating integrated experimental designs. Researchers should:
Employ multiparameter flow cytometry to analyze T cell subsets expressing RANK/RANKL
Utilize co-culture systems with osteoclast precursors and immune cells to assess cross-talk
Implement conditional knockout models to evaluate tissue-specific effects
Apply single-cell RNA sequencing to identify cell-specific expression patterns
Develop in vitro systems that recapitulate the bone marrow microenvironment
These approaches acknowledge that hematopoietic stem cells in the bone marrow are controlled by the immune system and work in concert with RANK/RANKL signaling, requiring methodologies that can detect subtle interactions between these systems.
Academic research institutions typically establish three categories of research ranks with distinct responsibilities and career trajectories. At Yale School of Medicine, these include Associate Research Scientist (ARS), Research Scientist (RS), and Senior Research Scientist (SRS) . Methodologically, these positions are defined by increasing levels of research independence and expertise:
Research Rank | Primary Responsibilities | Funding Expectations |
---|---|---|
Associate Research Scientist | Conduct research as skilled member of research group | Support typically derived from PI sponsor |
Research Scientist | Oversee research components with greater independence | May contribute to grant applications |
Senior Research Scientist | Lead research initiatives with high-level expertise | May secure independent funding streams |
Research rank faculty conduct or oversee research as skilled or advanced members of research groups, centers, or cores, typically with support derived from PI sponsors or research programs . While teaching is not required for these positions, those who undertake teaching responsibilities should receive appropriate teaching appointments and compensation adjustments.
Global ranking of academic subjects utilizes objective indicators and third-party data to measure university performance across disciplines. The ShanghaiRanking Global Ranking of Academic Subjects (GRAS) evaluates universities across 55 subjects including relevant fields in Natural Sciences, Life Sciences, Medical Sciences, and Social Sciences . Methodologically, these rankings employ five major evaluation categories:
World-Class Faculty
World-Class Output
High Quality Research
Research Impact
International Collaboration
The evaluation incorporates the Academic Excellence Survey (AES) conducted by ShanghaiRanking to assess international academic awards . Researchers should understand these ranking methodologies when evaluating potential collaborations or positioning their work within the global research landscape, particularly for interdisciplinary RANK/RANKL studies that may span multiple subject categories.
Researchers seeking to optimize their publications for academic search visibility should implement structured content approaches similar to those used for ranking in Google's People Also Ask (PAA) feature. While commercial SEO techniques are not directly applicable to academic publishing, the underlying principles of content organization remain valuable. Methodologically, researchers should:
Structure papers with clear, question-based section headings that anticipate reader queries
Provide comprehensive coverage of topics with "relevant info, value add, and extensive coverage"
Include well-structured content that is easy to read with logical flow between sections
Incorporate "bonus" content that addresses related questions readers might have
Ensure papers contain appropriate metadata and keywords for academic search engines
These approaches enhance discoverability without compromising academic integrity, enabling researchers to effectively communicate their RANK/RANKL findings to the broader scientific community.
Generating high-impact RANK/RANKL research requires careful experimental design that addresses both strengths and limitations of controlled studies. Methodologically, researchers should implement approaches that balance precision with real-world applicability:
Design Consideration | Implementation Strategy | Importance in RANK/RANKL Research |
---|---|---|
Control of Variables | Precise standardization of experimental conditions | Critical for isolating pathway effects |
Randomization | Random assignment to experimental groups | Minimizes selection bias |
Ecological Validity | Supplementing lab studies with real-world observations | Ensures translational relevance |
Observer Effects | Blinding procedures where feasible | Reduces experimental bias |
Replicability | Detailed methodology documentation | Enables validation by other researchers |
When designing RANK/RANKL studies, researchers should recognize that while lab experiments allow precise identification of cause-effect relationships, they may lack ecological validity . Integrating multiple experimental approaches provides more comprehensive understanding of RANK/RANKL function in human physiology and pathology.
Contradictory findings in RANK/RANKL research require methodological approaches that distinguish between true biological variability and experimental artifacts. When faced with inconsistent results, researchers should:
Systematically compare experimental conditions across studies to identify procedural differences
Evaluate cellular contexts and tissue sources, as RANK/RANKL expression varies across different tissues
Consider genetic background differences in study populations
Assess temporal dimensions of RANK/RANKL signaling, which may produce different outcomes at various time points
Implement meta-analytical approaches to quantitatively evaluate contradictory findings
This methodological framework acknowledges that RANK and RANKL "are expressed in a wide variety of tissues" with context-dependent functions, potentially explaining apparent contradictions in research findings.
Statistical analysis of individual variability in RANK/RANKL studies requires methodologies that account for complex trait genomics. Drawing from approaches used in toxicology prediction studies, researchers should implement:
Mixed modeling approaches that incorporate both fixed and random effects
Machine learning algorithms calibrated for modest correlation expectations (r < 0.28 for individual predictions)
Bayesian methods that can incorporate prior knowledge about RANK/RANKL function
Population stratification analyses to identify subgroups with distinct response patterns
Longitudinal statistical approaches for temporal expression pattern analysis
These statistical methodologies acknowledge the inherent complexity of predicting individual responses while providing frameworks for meaningful data interpretation, particularly when analyzing "interindividual variability of toxic response from genomic profiles" or similar RANK/RANKL expression variability.
RANK is a type I transmembrane protein that interacts with its ligand, RANKL (Receptor Activator of Nuclear Factor κ B Ligand), to activate downstream signaling pathways. The binding of RANKL to RANK triggers the activation of NF-κB (Nuclear Factor κ B), a transcription factor that regulates the expression of genes involved in osteoclast differentiation, survival, and function .
The RANK/RANKL signaling pathway is essential for the formation, function, and survival of osteoclasts, which are the cells responsible for bone resorption. When RANKL binds to RANK, it promotes the differentiation of osteoclast precursors into mature osteoclasts and enhances their bone-resorbing activity. This process is tightly regulated by osteoprotegerin (OPG), a decoy receptor that binds to RANKL and prevents it from interacting with RANK .
Abnormalities in the RANK/RANKL/OPG system can lead to various bone disorders. For example, excessive RANKL activity can result in increased bone resorption and conditions such as osteoporosis, rheumatoid arthritis, and bone metastases. Conversely, insufficient RANKL activity can impair bone remodeling and lead to osteopetrosis .
Recombinant human RANK is a genetically engineered version of the natural receptor, produced using recombinant DNA technology. It is commonly used in research to study the RANK/RANKL signaling pathway and its role in bone metabolism and immune responses. Recombinant human RANK is typically expressed in cell lines such as HEK293 cells and is used in various assays to screen for inhibitors of RANKL/RANK signaling .